What is the role of Burch colposuspension in treating stress urinary incontinence (SUI) in women?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: January 1, 2026View editorial policy

Personalize

Help us tailor your experience

Which best describes you? Your choice helps us use language that's most understandable for you.

Burch Colposuspension for Stress Urinary Incontinence

Primary Recommendation

Burch colposuspension remains a viable surgical option for stress urinary incontinence (SUI), but is now primarily reserved for women who refuse synthetic mesh or who are undergoing concurrent open/minimally invasive abdominal-pelvic surgery. 1

Current Position in Treatment Algorithm

When to Offer Burch Colposuspension

  • First-line consideration: Women with SUI who specifically decline synthetic mesh after thorough counseling about mesh risks and benefits 1
  • Opportunistic indication: Women undergoing concomitant open, laparoscopic, or robotic abdominal-pelvic surgery (e.g., hysterectomy, sacrocolpopexy) 1
  • Acceptable alternative: When autologous fascia pubovaginal sling is not feasible or desired 1

Efficacy Data

  • Short-term success (12-23 months): 81-82% cure/dry rates for open Burch 1
  • Medium-term (24-47 months): 76% cure/dry rates 1
  • Long-term (≥48 months): 73-78% cure/dry rates 1, 2
  • Laparoscopic approach: 69-74% cure/dry rates, with comparable outcomes to open technique 1, 3

Comparative Effectiveness

Burch vs. Autologous Fascial Sling

The SISTEr trial demonstrated autologous fascial pubovaginal sling superiority over Burch colposuspension, with 66% vs. 49% success rates and lower re-treatment rates at 5-year follow-up. 1 This represents the highest quality comparative data and should guide decision-making when both options are available.

Burch vs. Synthetic Midurethral Slings

  • Retropubic midurethral slings (TVT) show essentially equivalent outcomes to Burch colposuspension in multiple RCTs 1
  • Synthetic midurethral slings demonstrate 84% cure/dry rates at short and long-term follow-up 1
  • Critical distinction: Midurethral slings have become the most studied anti-incontinence procedure with comparable efficacy but less invasive approach 1

Complication Profile

Urge Incontinence Risk

  • De novo urge incontinence: 8% for open Burch without concurrent prolapse repair 1
  • De novo urge incontinence with prolapse repair: 14% 1
  • Preexisting urge incontinence: 17% postoperative persistence without prolapse repair, 22% with concurrent prolapse repair 1

Urinary Retention Risk

  • Retention >1 month or requiring intervention: 3-4% for open Burch 1
  • With concurrent prolapse repair: 1% retention rate 1
  • Notably lower than autologous fascial slings (8% retention) and synthetic bladder neck slings (9-10% retention) 1

Operative Considerations

  • Temporary urinary retention is the most common postoperative complaint 4
  • 19% experience urgency at 6-12 months postoperatively 4
  • 12% develop rectocele or enterocele requiring surgical correction after one year 4

Special Clinical Scenarios

Concomitant Prolapse Surgery

When performing abdominal sacrocolpopexy in women without preoperative stress incontinence symptoms, adding Burch colposuspension significantly reduces postoperative stress incontinence (33.6% vs. 57.4%, P<0.001) without increasing urge symptoms. 5 This represents high-quality evidence (NEJM, 2006) supporting prophylactic Burch during prolapse repair.

Recurrent Stress Incontinence

  • Primary surgery success rate: 95% 4
  • Recurrent SUI after prior surgery: 82% cure rate 4
  • Most failures occur within the first 6 months postoperatively 4, 2

Patients with Low Urethral Closure Pressure

For patients with intrinsic sphincter deficiency (low urethral closure pressure), vaginal sling procedures are preferable to Burch colposuspension. 2 This represents a critical patient selection factor to avoid predictable failure.

Technical Approach Options

Open vs. Laparoscopic

  • Open approach: 81-82% cure rates at 12-23 months 1
  • Laparoscopic/extraperitoneal approach: 69% cure rates with significant quality of life improvements and fewer apparent compromises in outcomes 1, 3
  • Both approaches show durable long-term results without significant differences 3

Suture Material

  • No significant differences between polyglycolic acid (Dexon) and polyglyconate monofilament absorbable sutures (Maxon) 4

Critical Pitfalls to Avoid

  • Patient selection error: Do not offer Burch to patients with intrinsic sphincter deficiency/low urethral closure pressure—these patients require pubovaginal slings or bulking agents 2
  • Inadequate preoperative counseling: Must discuss that autologous fascial slings have superior long-term outcomes with lower re-treatment rates 1
  • Ignoring concurrent prolapse: When performing sacrocolpopexy, prophylactic Burch significantly reduces postoperative SUI 5
  • Expecting mesh-equivalent outcomes: Burch has lower success rates than synthetic midurethral slings in most comparative studies, though differences may be modest 1

Preoperative Evaluation Requirements

  • Mandatory urodynamic evaluation to identify low urethral closure pressure patients who will fail Burch 2
  • Postoperative urodynamic studies unnecessary if clinical results are satisfactory 2
  • Cured patients demonstrate significant rise in pressure transmission from bladder to urethra 2

References

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.